CGRP-targeted therapies for migraine and the risk of infection.

Tana C, Raffaelli B, Messina R, Ornello R, Wells-Gatnik W, Martelletti P, Moffa L

Open source

DOI
10.1007/s11739-026-04403-0
Published
2026 Sep
Container
Internal and emergency medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11739-026-04403-0,
  title = {CGRP-targeted therapies for migraine and the risk of infection.},
  author = {Tana C and Raffaelli B and Messina R and Ornello R and Wells-Gatnik W and Martelletti P and Moffa L},
  year = {2026},
  journal = {Internal and emergency medicine},
  doi = {10.1007/s11739-026-04403-0},
  url = {https://doi.org/10.1007/s11739-026-04403-0}
}

RIS

TY  - JOUR
TI  - CGRP-targeted therapies for migraine and the risk of infection.
AU  - Tana C
AU  - Raffaelli B
AU  - Messina R
AU  - Ornello R
AU  - Wells-Gatnik W
AU  - Martelletti P
AU  - Moffa L
PY  - 2026
JO  - Internal and emergency medicine
DO  - 10.1007/s11739-026-04403-0
UR  - https://doi.org/10.1007/s11739-026-04403-0
ER  - 

APA

C, T., B, R., R, M., R, O., W, W., P, M., & L, M. (2026). CGRP-targeted therapies for migraine and the risk of infection.. Internal and emergency medicine. https://doi.org/10.1007/s11739-026-04403-0

Source records